Flutamide (CAS 13311-84-7) is a critical non-steroidal anti-androgen pharmaceutical compound widely used in the treatment of prostate cancer and benign prostatic hyperplasia across global healthcare systems. As a high-demand specialty pharmaceutical API (Active Pharmaceutical Ingredient) and finished drug formulation, Flutamide maintains consistent cross-border trade activity between manufacturing hubs and international pharmaceutical distributors, hospital procurement agencies, and licensed drug importers. A curated Flutamide global buyers list serves as an essential B2B resource for pharmaceutical manufacturers, chemical suppliers, and export-focused healthcare businesses looking to establish legitimate, long-term trade partnerships. This guide breaks down verified buyer demographics, top importing regions, core buyer categories, and key sourcing standards that define the global Flutamide trade…